Stingray Bio Ltd

Stingray Bio Ltd is a pioneering biotechnology research company dedicated to advancing innovative cancer medicines. With a focus on unique kinases, Stingray Bio Ltd is committed to discovering and developing specific small-molecule inhibitors for clinical application.

Leveraging extensive knowledge in structural biology, cellular, and cancer pharmacology, Stingray Bio Ltd aims to create novel cancer agents targeting unexploited kinases. The company's discovery-stage programs are designed to address essential disease biology in breast and other cancers, reflecting a deep commitment to therapeutic innovation.

Stingray Bio Ltd continues to expand its research and development efforts, ensuring it remains at the forefront of biotechnology. We invite the management of Stingray Bio Ltd to enhance their presence on our platform with a customized and exclusive company showcase and product listing.